documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
3,009 rows where document_type = "Other" and posted_year = 2012 sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: posted_month, open_for_comment, withdrawn, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1975-N-0012-0196 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Citizen Petition from Ciba Specialty Chemicals Corporation | Other | Citizen Petition | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-11-22T17:13:28Z | 0 | 0 | 09000064805c1b33 | ||
| FDA-1975-N-0012-0197 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Acknowledgment Letter from FDA/DDM to Ciba Specialty Chemicals Corporation | Other | Acknowledgement Letter/Receipt | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-11-27T15:57:51Z | 0 | 0 | 09000064805c1b34 | ||
| FDA-1975-N-0012-0198 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Supplement from Ciba Specialty Chemicals Corporation | Other | Supplement (SUP) | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-11-22T17:41:18Z | 0 | 0 | 09000064805c1b35 | ||
| FDA-2012-S-1178-0015 | FDA | FDA-2012-S-1178 | NDI 734, Heat-Killed Lactobacillus Plantarum L-137 (HK-LP), Immuno-LP20 from House Wellness Foods Corporation | Other | 75 Day PreMarket Notification | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2016-10-27T15:19:56Z | 0 | 0 | 0900006481199880 | ||
| FDA-2012-S-1178-0017 | FDA | FDA-2012-S-1178 | NDI 736, Tall Oil Phytoesters from Forbes Medi-Tech Corporation | Other | 75 Day PreMarket Notification | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2016-10-27T15:19:56Z | 0 | 0 | 0900006481199883 | ||
| FDA-1980-N-0004-0008 | FDA | Over-the-Counter Ophthalmic Drug Products for Emergency First Aid Use; Proposed Amendment of Final Monograph for Over-the-Counter Opthalmic Drug Products FDA-1980-N-0004 | Acknowledgement Letter to Ferenc Kuhn, M.D., Ph.D. and Wendell J. Scott M.D. | Other | Acknowledgement Letter/Receipt | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T19:33:40Z | 0 | 0 | 090000648119e74e | ||
| FDA-1980-N-0004-0007 | FDA | Over-the-Counter Ophthalmic Drug Products for Emergency First Aid Use; Proposed Amendment of Final Monograph for Over-the-Counter Opthalmic Drug Products FDA-1980-N-0004 | Citizen Petition from Ferenc Kuhn, MD., Ph.D. and Wendell J. Scott M.D. | Other | Citizen Petition | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2024-11-12T05:09:22Z | 1 | 0 | 090000648119e74c | ||
| FDA-2012-P-1265-0001 | FDA | FDA-2012-P-1265 | Indicus Pharma LLC - Citzen Petition | Other | Citizen Petition | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2019-01-19T02:05:18Z | 0 | 0 | 090000648119e750 | ||
| FDA-2012-P-1265-0002 | FDA | FDA-2012-P-1265 | Acknowledgement Letter to Indicus Pharma LLC | Other | Acknowledgement Letter/Receipt | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T19:12:37Z | 0 | 0 | 090000648119e753 | ||
| FDA-2012-E-1245-0001 | FDA | FDA-2012-E-1245 | The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application | Other | Application | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T21:46:33Z | 0 | 0 | 09000064811a0ce5 | ||
| FDA-1975-N-0012-0194 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Citizen Petition from Bayer Corporation | Other | Citizen Petition | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-11-27T15:04:09Z | 0 | 0 | 09000064805c1b30 | ||
| FDA-1975-N-0012-0221 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Supplement from Aplicare Inc. | Other | Supplement (SUP) | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-10-30T15:11:18Z | 0 | 0 | 09000064805c1c9b | ||
| FDA-2012-E-1244-0002 | FDA | FDA-2012-E-1244 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T21:17:55Z | 0 | 0 | 09000064811a0ce3 | ||
| FDA-2012-P-0661-0003 | FDA | FDA-2012-P-0661 | Interim Response Letter from FDA CDER to Sandoz, Inc. | Other | Letter(s) | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2019-03-14T17:26:53Z | 0 | 0 | 09000064811a0c2e | ||
| FDA-1975-N-0012-0195 | FDA | Health Care Antiseptic Drug Products for Over-the-Counter (OTC) Human Use; CLOSED FDA-1975-N-0012 | Acknowledgment Letter from FDA/DDM to Bayer Corporation | Other | Acknowledgement Letter/Receipt | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2017-10-24T19:34:23Z | 0 | 0 | 09000064805c1b31 | ||
| FDA-2012-S-1178-0019 | FDA | FDA-2012-S-1178 | NDI 738, Antrodia Cinnamomea Extract from WinPal LLC | Other | 75 Day PreMarket Notification | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2016-10-27T15:19:56Z | 0 | 0 | 0900006481199885 | ||
| FDA-2012-P-1267-0001 | FDA | FDA-2012-P-1267 | Xspire Pharma, LLC - Citizen Petition | Other | Citizen Petition | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2024-11-12T05:11:10Z | 1 | 0 | 090000648119ff73 | ||
| FDA-2010-P-0188-0016 | FDA | FDA-2010-P-0188 | AXIN, Veltrop & Harkrider LLP (Actavis Elizabeth LLC) - Withdrawal of Citizen Petition | Other | Withdrawal | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T17:34:48Z | 0 | 0 | 09000064811a0997 | ||
| FDA-2012-S-1178-0016 | FDA | FDA-2012-S-1178 | NDI 735, Euphovida (3-Phytase), EUPHOVIDA TM from DSM Food Specialties | Other | 75 Day PreMarket Notification | 2012-12-31T05:00:00Z | 2012 | 12 | 2016-10-27T15:19:56Z | 0 | 0 | 0900006481199882 | |||
| FDA-2012-E-1244-0001 | FDA | FDA-2012-E-1244 | The Henry M. Jackson Foundation for the Advancement of Military Meicine (Finnegan, Henderson, et al) - Patent Extension Application | Other | Application | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T21:39:13Z | 0 | 0 | 09000064811a0cc1 | ||
| FDA-2012-S-1178-0018 | FDA | FDA-2012-S-1178 | NDI 737, Syringa Vulgaris Extract, I.R.B. lstituto di Ricerche Biotecnologiche S.p.A. | Other | 75 Day PreMarket Notification | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2016-10-27T15:19:56Z | 0 | 0 | 0900006481199884 | ||
| FDA-2012-E-1245-0002 | FDA | FDA-2012-E-1245 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T21:46:33Z | 0 | 0 | 09000064811a0ce7 | ||
| FDA-2012-P-1267-0002 | FDA | FDA-2012-P-1267 | Acknowledgement Letter to Xspire Pharma, LLC | Other | Acknowledgement Letter/Receipt | 2012-12-31T05:00:00Z | 2012 | 12 | 2012-12-31T05:00:00Z | 2012-12-31T19:41:32Z | 0 | 0 | 090000648119ff76 | ||
| FDA-2012-P-1259-0001 | FDA | FDA-2012-P-1259 | Hyman Phelps McNamara PC - Citizen Petition | Other | Citizen Petition | 2012-12-30T05:00:00Z | 2012 | 12 | 2012-12-30T05:00:00Z | 2024-11-12T05:11:55Z | 1 | 0 | 090000648119d635 | ||
| FDA-2012-P-1259-0002 | FDA | FDA-2012-P-1259 | Acknowledgement Letter to Hyman, Phelps & McNamara, PC | Other | Acknowledgement Letter/Receipt | 2012-12-30T05:00:00Z | 2012 | 12 | 2012-12-30T05:00:00Z | 2012-12-31T01:04:14Z | 0 | 0 | 090000648119d736 | ||
| FDA-2011-E-0133-0007 | FDA | FDA-2011-E-0133 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2024-03-13T11:51:10Z | 0 | 0 | 090000648119d5e1 | ||
| FDA-2012-E-1237-0001 | FDA | FDA-2012-E-1237 | Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T16:13:29Z | 0 | 0 | 090000648119df04 | ||
| FDA-2012-E-1236-0001 | FDA | FDA-2012-E-1236 | Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:44:12Z | 0 | 0 | 090000648119dbad | ||
| FDA-1995-S-0036-0135 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Resuscitation Outcomes Consortium (ROC) re IND 110280, British Columbia, Canada Public Disclosure Material Report 63 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:04Z | 0 | 0 | 090000648118f830 | ||
| FDA-2011-E-0153-0007 | FDA | FDA-2011-E-0153 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:09:25Z | 0 | 0 | 090000648119d582 | ||
| FDA-2010-E-0399-0008 | FDA | FDA-2010-E-0399 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:49:24Z | 0 | 0 | 090000648119d5de | ||
| FDA-2007-E-0482-0009 | FDA | FDA-2007-E-0482 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T12:41:20Z | 0 | 0 | 090000648119d087 | ||
| FDA-2007-E-0278-0013 | FDA | FDA-2007-E-0278 | FDA/CDER to Covington & Burling LLP (Merck & Co., Inc.) - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:23:52Z | 0 | 0 | 090000648119d5dc | ||
| FDA-2012-E-1235-0002 | FDA | FDA-2012-E-1235 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:01:20Z | 0 | 0 | 090000648119d26b | ||
| FDA-2012-E-1237-0002 | FDA | FDA-2012-E-1237 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T16:13:31Z | 0 | 0 | 090000648119e02b | ||
| FDA-2011-E-0136-0008 | FDA | FDA-2011-E-0136 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2024-03-13T11:49:37Z | 0 | 0 | 090000648119d5e4 | ||
| FDA-1995-S-0036-0136 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | University of Texas Health Science Center at Houston re IND 14929, University of Alabama Public Disclosure Material Report 64 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:18Z | 0 | 0 | 090000648118f832 | ||
| FDA-2010-E-0663-0006 | FDA | FDA-2010-E-0663 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:09:35Z | 0 | 0 | 090000648119d090 | ||
| FDA-1995-S-0036-0137 | FDA | Public Disclosure Materials for Emergency Research Studies Conducted Under 21 CFR 50.24 FDA-1995-S-0036 | Rampart Neurological Emergencies Treatment Trials Neuro Emergencies Research, Community Consultion and Public Disclosure IND 102254 Report 65 - Report | Other | Report | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2014-11-28T19:44:31Z | 0 | 0 | 090000648119e1fd | ||
| FDA-2012-E-1241-0003 | FDA | FDA-2012-E-1241 | Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Supplement | Other | Supplement (SUP) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T17:24:52Z | 0 | 0 | 090000648119e0e9 | ||
| FDA-2012-V-1222-0002 | FDA | FDA-2012-V-1222 | Acknowledgement Letter to Simply Automation | Other | Acknowledgement Letter/Receipt | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T15:16:11Z | 0 | 0 | 090000648118faf9 | ||
| FDA-2012-E-1234-0001 | FDA | FDA-2012-E-1234 | Mitsubishi Tenabe Pharma Corp. (Finnegan, Henderson, Farabow, Garrett & Dunner LLP) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:10:24Z | 0 | 0 | 090000648119d265 | ||
| FDA-2012-E-1236-0002 | FDA | FDA-2012-E-1236 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:44:12Z | 0 | 0 | 090000648119dbaf | ||
| FDA-2012-E-1241-0001 | FDA | FDA-2012-E-1241 | Abbott Cardiovascular Systems Inc. (Baker Botts, LLP) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T17:24:50Z | 0 | 0 | 090000648119e0e4 | ||
| FDA-2012-E-1243-0002 | FDA | FDA-2012-E-1243 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T21:50:47Z | 0 | 0 | 090000648119eb02 | ||
| FDA-2012-E-1235-0001 | FDA | FDA-2012-E-1235 | Genentech, Inc. (Morrison & Foerster LLP) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T14:01:19Z | 0 | 0 | 090000648119d269 | ||
| FDA-2012-V-1222-0001 | FDA | FDA-2012-V-1222 | Simply Automation - Application for Variance | Other | Application for Variance (VAR) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T15:16:10Z | 0 | 0 | 090000648118faa9 | ||
| FDA-2012-E-1234-0002 | FDA | FDA-2012-E-1234 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:10:25Z | 0 | 0 | 090000648119d267 | ||
| FDA-2011-E-0139-0007 | FDA | FDA-2011-E-0139 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:00:15Z | 0 | 0 | 090000648119d08b | ||
| FDA-2011-E-0371-0007 | FDA | FDA-2011-E-0371 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:21:29Z | 0 | 0 | 090000648119d57c | ||
| FDA-2011-E-0168-0007 | FDA | FDA-2011-E-0168 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2024-03-13T11:33:47Z | 0 | 0 | 090000648119d580 | ||
| FDA-2010-E-0049-0007 | FDA | FDA-2010-E-0049 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T12:50:18Z | 0 | 0 | 090000648119d089 | ||
| FDA-2011-E-0379-0007 | FDA | FDA-2011-E-0379 | FDA/CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T13:27:04Z | 0 | 0 | 090000648119d57e | ||
| FDA-2012-E-1243-0001 | FDA | FDA-2012-E-1243 | Durand Wayland Inc. (Altera Law Group LLC) - Patent Extension Application | Other | Application | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T21:50:46Z | 0 | 0 | 090000648119eadf | ||
| FDA-2012-E-1241-0002 | FDA | FDA-2012-E-1241 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-28T05:00:00Z | 2012 | 12 | 2012-12-28T05:00:00Z | 2012-12-28T17:24:51Z | 0 | 0 | 090000648119e0e6 | ||
| FDA-2012-S-1178-0009 | FDA | FDA-2012-S-1178 | NDI 727 17a-Hydroxypregna-1,4-Diene-3,20-Dione 1,4-Diene from Proprietary Wellness | Other | 75 Day PreMarket Notification | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2016-10-27T15:19:55Z | 0 | 0 | 0900006480fac72b | ||
| FDA-2012-E-1246-0001 | FDA | FDA-2012-E-1246 | Medtronic, Inc. (Sterne Kessler Goldstein & Fox PLLC) - Patent Extension Application | Other | Application | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T23:16:14Z | 0 | 0 | 090000648119cae1 | ||
| FDA-2001-V-0062-0009 | FDA | SKI Dazzle Laser Show FDA-2001-V-0062 | FDA/CDRH to DayStar Lasers International, LLC - Approval for Variance | Other | Approval for Variance (VRA) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T16:35:26Z | 0 | 0 | 090000648119b78c | ||
| FDA-2012-E-1233-0002 | FDA | FDA-2012-E-1233 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-28T00:24:28Z | 0 | 0 | 090000648119ceef | ||
| FDA-2012-E-1226-0002 | FDA | FDA-2012-E-1226 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T23:14:08Z | 0 | 0 | 090000648119ce85 | ||
| FDA-2012-E-1232-0002 | FDA | FDA-2012-E-1232 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T23:56:54Z | 0 | 0 | 090000648119ce89 | ||
| FDA-2012-E-1232-0001 | FDA | FDA-2012-E-1232 | Arena Pharmaceuticals, Inc. (Finnegan Henderson LLP) - Patent Extension Application | Other | Application | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T23:56:33Z | 0 | 0 | 090000648119ce87 | ||
| FDA-2012-S-1178-0011 | FDA | FDA-2012-S-1178 | NDI 729, HT 1001: Panax quinquefolius (American ginseng) from Afexa Life Sciences, Inc. | Other | 75 Day PreMarket Notification | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2016-10-27T15:19:55Z | 0 | 0 | 0900006480fac757 | ||
| FDA-2012-S-1178-0010 | FDA | FDA-2012-S-1178 | NDI 728 Terminalia chebula from Hikmeth Corporation | Other | 75 Day PreMarket Notification | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2016-10-27T15:19:55Z | 0 | 0 | 0900006480fac748 | ||
| FDA-2011-E-0152-0007 | FDA | FDA-2011-E-0152 | FDA\CDER to United States Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T18:17:27Z | 0 | 0 | 090000648119c9b4 | ||
| FDA-2010-E-0334-0009 | FDA | FDA-2010-E-0334 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T15:16:22Z | 0 | 0 | 090000648119c5b0 | ||
| FDA-2010-E-0662-0006 | FDA | FDA-2010-E-0662 | FDA\CDER to United States Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T19:53:47Z | 0 | 0 | 090000648119cadb | ||
| FDA-2012-E-1247-0002 | FDA | FDA-2012-E-1247 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T22:11:52Z | 0 | 0 | 090000648119ce81 | ||
| FDA-2010-E-0659-0008 | FDA | FDA-2010-E-0659 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T14:53:05Z | 0 | 0 | 090000648119c5ac | ||
| FDA-2011-E-0246-0007 | FDA | FDA-2011-E-0246 | FDA\CDER to U.S. Patent and Trademark Office Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T16:46:12Z | 0 | 0 | 090000648119c8d0 | ||
| FDA-2011-E-0245-0007 | FDA | FDA-2011-E-0245 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2024-03-13T11:31:53Z | 0 | 0 | 090000648119c8ce | ||
| FDA-2011-E-0389-0008 | FDA | FDA-2011-E-0389 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T15:51:29Z | 0 | 0 | 090000648119c7d6 | ||
| FDA-2012-S-1178-0014 | FDA | FDA-2012-S-1178 | NDI 733, E. Coli Strain Nissle 1917 and Mutaflor from Medical Futures Inc. | Other | 75 Day PreMarket Notification | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2016-10-27T15:19:56Z | 0 | 0 | 09000064811961c4 | ||
| FDA-2012-E-1246-0002 | FDA | FDA-2012-E-1246 | U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T21:16:32Z | 0 | 0 | 090000648119cc3c | ||
| FDA-2012-V-1078-0003 | FDA | FDA-2012-V-1078 | FDA/CDRH to Nicky-B Entertainment - Approval for Variance | Other | Approval for Variance (VRA) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T17:10:11Z | 0 | 0 | 090000648119b800 | ||
| FDA-2011-E-0380-0008 | FDA | FDA-2011-E-0380 | FDA\CDER to U.S. Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T15:45:07Z | 0 | 0 | 090000648119c5b5 | ||
| FDA-2011-E-0113-0007 | FDA | FDA-2011-E-0113 | FDA\CDER to United States Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T20:10:42Z | 0 | 0 | 090000648119cadd | ||
| FDA-2012-S-1178-0012 | FDA | FDA-2012-S-1178 | NDI 731, 3,5-Diiodo-L-Thryonine and Proprietary Wellness | Other | 75 Day PreMarket Notification | 2012-12-27T05:00:00Z | 2012 | 12 | 2011-10-05T04:00:00Z | 2016-10-27T15:19:55Z | 0 | 0 | 09000064811961bd | ||
| FDA-2011-E-0156-0007 | FDA | FDA-2011-E-0156 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2024-03-13T11:35:54Z | 0 | 0 | 090000648119c23a | ||
| FDA-2011-E-0114-0007 | FDA | FDA-2011-E-0114 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2024-03-13T11:58:33Z | 0 | 0 | 090000648119c7dd | ||
| FDA-2011-E-0014-0007 | FDA | FDA-2011-E-0014 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2024-03-13T12:03:47Z | 0 | 0 | 090000648119c23f | ||
| FDA-2010-E-0333-0009 | FDA | FDA-2010-E-0333 | FDA\CDER to U.S. Patent and Trademark Office Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T15:24:03Z | 0 | 0 | 090000648119c5b2 | ||
| FDA-2012-D-1197-0005 | FDA | FDA-2012-D-1197 | The Honorable Pete Olson et al to the Commissioner, FDA - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2013-02-28T21:04:16Z | 0 | 0 | 090000648119b8ac | ||
| FDA-2010-E-0660-0007 | FDA | FDA-2010-E-0660 | FDA\CDER to U.S. Patent and Trademark Office - Lettero | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T15:02:27Z | 0 | 0 | 090000648119c5ae | ||
| FDA-2012-P-1180-0003 | FDA | FDA-2012-P-1180 | Lannett Company, Inc. - Amendment | Other | Amendment | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-28T02:52:05Z | 0 | 0 | 090000648119cd8a | ||
| FDA-2012-E-1247-0001 | FDA | FDA-2012-E-1247 | Arena Pharmaceuticals Inc. (Finnegan, Henderson, Farabow, Garrett & Dunner, LLP) - Patent Extension Application | Other | Application | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T22:11:52Z | 0 | 0 | 090000648119cde1 | ||
| FDA-2012-E-1233-0001 | FDA | FDA-2012-E-1233 | Toshiaki Miyake, et al (Wenderoth, Lind & Ponack LLP) - Patent Extension Application | Other | Application | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-28T00:24:28Z | 0 | 0 | 090000648119ceed | ||
| FDA-2011-E-0141-0008 | FDA | FDA-2011-E-0141 | Letter to U. S. Patent and Trademark Office | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2024-03-13T12:14:04Z | 0 | 0 | 090000648119ca05 | ||
| FDA-2012-E-1226-0001 | FDA | FDA-2012-E-1226 | LEO Laboratories (Edwards, Wildman, Palmer LLP) - Patent Extension Application | Other | Application | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T23:11:19Z | 0 | 0 | 090000648119ce83 | ||
| FDA-2010-E-0661-0007 | FDA | FDA-2010-E-0661 | FDA\CDER to United States Patent and Trademark Office - Letter | Other | Letter(s) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T19:42:58Z | 0 | 0 | 090000648119ca07 | ||
| FDA-2012-V-1008-0003 | FDA | FDA-2012-V-1008 | FDA/CDRH to Sound and Lighting Designs - Approval for Variance | Other | Approval for Variance (VRA) | 2012-12-27T05:00:00Z | 2012 | 12 | 2012-12-27T05:00:00Z | 2012-12-27T17:18:33Z | 0 | 0 | 090000648119b804 | ||
| FDA-2012-P-0695-0009 | FDA | FDA-2012-P-0695 | Interim Response to Lorillard Tobacco Company | Other | Letter(s) | 2012-12-26T05:00:00Z | 2012 | 12 | 2012-12-26T05:00:00Z | 2012-12-26T15:13:51Z | 0 | 0 | 090000648119a1e3 | ||
| FDA-2012-P-0779-0005 | FDA | FDA-2012-P-0779 | FDA/CDER to Valeant Pharmaceuticals Intl., Inc. - Petition Denial Correction | Other | Correction(s) | 2012-12-26T05:00:00Z | 2012 | 12 | 2012-12-26T05:00:00Z | 2012-12-26T18:20:49Z | 0 | 0 | 090000648119ab94 | ||
| EPA-HQ-OA-2012-0987-0002 | EPA | Semiannual Regulatory Agenda - Fall 2012 EPA-HQ-OA-2012-0987 | Regulatory Plan - Fall 2012 | Other | Memorandum to Open a Docket | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2013-01-31T16:16:13Z | 0 | 0 | 0900006481199110 | ||
| EPA-HQ-OA-2012-0987-0001 | EPA | Semiannual Regulatory Agenda - Fall 2012 EPA-HQ-OA-2012-0987 | Semiannual Regulatory Agenda - Fall 2012 | Other | Memorandum to Open a Docket | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2013-01-31T16:15:52Z | 0 | 0 | 090000648119910f | ||
| FDA-1978-N-0023-0166 | FDA | Skin Bleaching Drug Products- OPEN FDA-1978-N-0023 | Report from Nonprescription Drug Manufacturers Association | Other | Report | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2019-09-25T19:25:17Z | 0 | 0 | 090000648055f19c | ||
| FDA-1978-N-0023-0167 | FDA | Skin Bleaching Drug Products- OPEN FDA-1978-N-0023 | Acknowledgment Letter from FDA DDM to Michael T. Benson | Other | Acknowledgement Letter/Receipt | 2012-12-24T05:00:00Z | 2012 | 12 | 2019-09-13T15:31:17Z | 0 | 0 | 0900006480a3d7cf | |||
| FDA-1978-N-0023-0168 | FDA | Skin Bleaching Drug Products- OPEN FDA-1978-N-0023 | Supplement from Paul A. Lehman, M.Sc. and Thomas J. Franz, M.D. | Other | Supplement (SUP) | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2019-09-16T13:33:03Z | 0 | 0 | 090000648055fd10 | ||
| USDA-2012-0005-0001 | USDA | Semiannual Regulatory Agenda - Fall 2012 USDA-2012-0005 | Semiannual Regulatory Agenda - Fall 2012 | Other | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2013-01-12T22:29:33Z | 0 | 0 | 090000648119935d | |||
| USDA-2012-0005-0002 | USDA | Semiannual Regulatory Agenda - Fall 2012 USDA-2012-0005 | Regulatory Plan - Fall 2012 | Other | 2012-12-24T05:00:00Z | 2012 | 12 | 2012-12-24T05:00:00Z | 2012-12-27T19:15:34Z | 0 | 0 | 090000648119935e |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);